Anti-NGF-antibody administration as collyrium reduces the presence of NGF and enhances the expression of VEGF in the retina,lacrimal gland and hippocampus |
| |
| Authors: | Valeria Colafrancesco Francesca Cirulli Simona Rossi Alessandra Berry Luigi Aloe |
| |
| Institution: | 1. G.B. Bietti Eye Foundation, Via Livenza 3, 00198 Rome, Italy;2. Department of Cell Biology and Neurosciences, Behavioural Neuroscience Section, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy;3. Institute of Neurobiology and Molecular Medicine (NGF Section), National Research Council (CNR), Via del Fosso di Fiorano, 64/65, 00143 Rome, Italy |
| |
| Abstract: | In the present study we investigated the effects of eye anti-nerve growth factor (NGF)-antibody (ANA) application on the retina, lacrimal gland, and brain cells of aged mice. Mice were treated three times daily for three consecutive weeks with ANA or with pre-immune IgG. Then mice were sacrificed and retina and brain used for biochemical and immunohistochemical studies. Eye ANA application reduced the level of NGF and enhanced the expression of VEGF in all these three tissues. Moreover, ANA treatment reduced the number of basal forebrain neurons expressing choline acetyltransferase, ChAT, a cholinergic enzyme regulated by NGF. This observation is in line with previous reports showing that biologically active compounds, including high molecular weight proteins such as NGF and ANA, can be delivered by an alternative ocular route into the brain, allowing to understand the role of NGF and VEGF in retinal and brain cell degeneration and regeneration. |
| |
| Keywords: | Nerve growth factor Vascular endothelial growth factor Retina Lacrimal gland Hippocampus Choline acetyltransferase |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
